JP2007224032A - 黄斑変性症及び関連する眼の病気の治療方法 - Google Patents

黄斑変性症及び関連する眼の病気の治療方法 Download PDF

Info

Publication number
JP2007224032A
JP2007224032A JP2007039810A JP2007039810A JP2007224032A JP 2007224032 A JP2007224032 A JP 2007224032A JP 2007039810 A JP2007039810 A JP 2007039810A JP 2007039810 A JP2007039810 A JP 2007039810A JP 2007224032 A JP2007224032 A JP 2007224032A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
monolayer vesicle
composition according
pharmaceutical
macular degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007039810A
Other languages
English (en)
Japanese (ja)
Inventor
Milton Lethan Pressler
レザン プレスラー ミルトン
William Sasiela
サシーラ ウィリアム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of JP2007224032A publication Critical patent/JP2007224032A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2007039810A 2006-02-21 2007-02-20 黄斑変性症及び関連する眼の病気の治療方法 Pending JP2007224032A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77552006P 2006-02-21 2006-02-21

Publications (1)

Publication Number Publication Date
JP2007224032A true JP2007224032A (ja) 2007-09-06

Family

ID=38226652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007039810A Pending JP2007224032A (ja) 2006-02-21 2007-02-20 黄斑変性症及び関連する眼の病気の治療方法

Country Status (4)

Country Link
JP (1) JP2007224032A (fr)
AR (1) AR059581A1 (fr)
TW (1) TW200744670A (fr)
WO (1) WO2007096744A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009107753A1 (fr) * 2008-02-29 2009-09-03 財団法人 名古屋産業科学研究所 Liposome pour une administration au segment postérieur de l'œil et composition pharmaceutique pour une maladie du segment postérieur de l'œil

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017184081A1 (fr) * 2016-04-19 2017-10-26 Nanyang Technological University Formulations formant un dépôt sous-conjonctival pour l'administration de médicament au niveau de l'œil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141018A1 (de) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
US20050260260A1 (en) * 2004-05-19 2005-11-24 Edward Kisak Liposome compositions for the delivery of macromolecules
CA2622475A1 (fr) * 2005-09-26 2007-04-05 Vasogen Ireland Limited Traitement d'inflammations et d'anomalies vasculaires de l'oeil

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009107753A1 (fr) * 2008-02-29 2009-09-03 財団法人 名古屋産業科学研究所 Liposome pour une administration au segment postérieur de l'œil et composition pharmaceutique pour une maladie du segment postérieur de l'œil
US9114070B2 (en) 2008-02-29 2015-08-25 Nagoya Industrial Science Research Institute Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye

Also Published As

Publication number Publication date
WO2007096744A1 (fr) 2007-08-30
TW200744670A (en) 2007-12-16
AR059581A1 (es) 2008-04-16

Similar Documents

Publication Publication Date Title
KR20050009988A (ko) 질병을 치료 또는 예방하기 위한 조성물 및 일정 크기의리포좀 투여방법
US20070254832A1 (en) Methods for the treatment of macular degeneration and related eye conditions
JP6535281B2 (ja) 関節炎の処置方法
JP2007509157A (ja) 急性冠症候群の処置および予防のための医薬製剤、方法および投与計画
JP2019517578A (ja) 異常な新生血管形成を伴う眼疾患を処置するためにニンテダニブを使用する組成物および方法
JP6231995B2 (ja) 眼の疾患の合併症を低減するための薬学的組成物
EP3238746B1 (fr) Lipoprotéine haute densité et administration de médicament au segment postérieur de l' oeil par instillation oculaire de ladite lipoprotéine haute densité fusionnée à un peptide cytophile
CN108057023B (zh) 重构的hdl配制剂
US8691874B2 (en) Treatment of ophthalmic disorders using urea
US20070197442A1 (en) Methods for the Treatment of Macular Degeneration and Related Eye Conditions
JP2007224032A (ja) 黄斑変性症及び関連する眼の病気の治療方法
JP5729735B2 (ja) ダルセトラピブのリポソーム製剤
AU711856B2 (en) Combination injection preparation
JP2003533476A (ja) 敗血症ショックの治療
ES2325360T3 (es) Tratamiento de trastornos oftalmicos usando urea y derivados de urea.
TWI786328B (zh) 緩釋眼用藥物組合物及其用途
JP2002518431A (ja) パルトリシン誘導体の注射可能な薬学的処方物
US20170128542A1 (en) Non-aqueous glucagon formulations
JPH10203979A (ja) チアプロフェン酸を含有する抗眼炎症剤
WO2002034250A1 (fr) Emulsions de matieres grasses
JPH02258727A (ja) γ―Ｌ―グルタミル―Ｌ―システインエステル誘導体を含有するリポソーム製剤
BRPI0705126B1 (pt) formulação farmacêutica para uso parenteral de compostos derivados de metotrexato associados a ésteres de colesterol

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20071003

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071003